Stop glamorizing the hustle and start glamorizing the mussel

This would make me an even bigger snob about learning french if I wasn’t already maxxed out on that particular dial

These colognes smell so good and make great gifts. That’s it, that’s the post. Powered by @sephora

Reason #239 why I believe in American leadership in science: I once asked a European regulator whether he would consider fast-tracking climate interventions if the alternative was certain destruction, and his answer was “of course not”

The application of humanoid robots that I’m the most excited about and one that will definitely work is super dope ass fortune teller machines

Victor frankenstein did nothing wrong

Just three more dollars a week! That's what the average ObamaCare enrollee will pay once the COVID-era ObamaCare subsidies expire. And it's why Democrats shut down the government—ignoring ObamaCare's failures in the process. FGA's @HaydenDublois for @NYPostOpinion. ⤵️

Will AI-generated genomes read like AI slop? Like you’ll be scrolling GenBank one day and it will be full of microbial genomes with the nucleotide equivalent of “This lac operon doesn’t just encode LacA and LacY — it expresses LacZ”

Maybe somebody should work out a biotech business model based on selling ads since apparently that is the most important and profitable thing on earth

We're living in a fun moment of Bio x AI where we have 1) A broad consensus that this is going to be a big deal 2) An almost perfect anti-consensus on the most basic questions of how AI for bio should be financed, organized, produced and made available

Easy to forget, as we ponder if our generative genome models will be utterly transformative or merely incremental, that the time when we didn’t even know what DNA was is still in living memory

AI agents at enterprise scale ⚡️ Designing the Giga brand. With the brilliant @varunvummadi @eshamanideep @jcarvajalpa

It may seem obvious but honestly it is worth taking a moment to reflect on how amazing this actually is

With EvolutionaryScale going from for-profit to non-profit, it low key seems like nobody knows the right way to finance AI x Bio In the next 5 years, which type of org do you think will produce the most impactful BioAI models?

What does it mean to be a Biocreative? 🧬🎨 @bygracechuang orchestrated branding for Ginkgo Bioworks' IPO, which was the largest of a biotech startup ever. There, she cofounded @growbyginkgo, an award-winning magazine about the societal aspects of synthetic biology, and she has

$595

News: Evolutionary Scale joining the CZI Biohub. I'm not a historian of the capital markets but... It can't be that common for a venture-backed business to "acquired" by a non-profit like this. Can it? Big implications for the future of AI x Bio https://t.co/BOcCP5e43q

We used to have a proper internet

Still, Sparkling or HUVE? The HUVE Perform hydrogen water bottle uses advanced electrolysis to infuse your water with molecular hydrogen - a powerful antioxidant, shown to help neutralize free radicals, reduce inflammation, and support recovery at the cellular level.

If you study cholinesterases in plant tissues you have legendary opportunity to make your work relatable to gen z by showing them this article from 1975 that has PubMed ID # 67 https://t.co/KT9PDsQdbq

Hoping we can get some East Coast / West Coast rivalry going that will inspire the next big Boston bio innovation center Come on Red Sox Nation we can't let @arcinstitute have all the fun!

Sold out of these cell free protein synthesis kits quickly the first time! 😄🧬Excited to be back in stock with a new and improved version, request a free sample below !!!👇

I asked Kosmos yesterday how many licks it takes to get to the center of a tootsie pop. It built a tribocorrosion model using the material properties of amorphous sucrose and told me the answer was 350.

Security Onion is not just NSM anymore! We started in 2008 as a Network Security Monitoring platform, but we've added so many features over the years! - endpoint visibility - log management - case management - deception - MCP - AI - and more! Check it out!

Let's say you had an AI scientist that could reliably design blockbuster drugs. Isn't the financial incentive to keep that incredible power for yourself? Curious about the economics here. How good does a model have to get before it no longer makes sense to let others use it?

Biotech needs more patient funders and impatient founders